Stocks›Healthcare›ACB

ACB

AURORA CANNABIS INC

NasdaqResearch view

HealthcareMedicinal Chemicals & Botanical ProductsSEC EDGAR FY 2022-06-30

Price history

Chart: TradingView’s own feed · page prices: 1D EOD

🔒 Click to interact · scroll moves the page

Snapshot

SEC EDGAR · FY 2022-06-30

SectorHealthcare

IncomeCAD -1.7B

SalesCAD 221.3M

Book/shCAD 11.84

Cash/shCAD 7.79

Dividend TTM—

Payout—

Employees—

IPO—

Quick Ratio4.81

Current Ratio5.69

Debt/Eq—

EPS (ttm)CAD 0.04

EPS this Y102.6%

EPS past 3/5Y—

Sales past 3/5Y-3.4%

EPS Y/Y TTM102.6%

Sales Y/Y TTM-9.8%

Shs Outstand56.23M

ROA-158.4%

ROE-258.0%

ROIC1.7%

Gross Margin9.6%

Oper. Margin2.2%

Profit Margin-776.2%

Every figure here is filed with the SEC. Valuation and estimate metrics (P/E, PEG, EV/EBITDA, price targets, forward EPS) are omitted until our market-data feed is licensed for display — we’d rather show fewer numbers than blank ones. Deeper lines (cash flow, balance sheet) below.

Revenue & Earnings — fiscal year

CAD 55.2M

2018

CAD 245.5M

2019

CAD 268.7M

2020

CAD 245.3M

2021

CAD 221.3M

2022

Financials — annual

SEC EDGAR · last 5 FY · tap a row to explain it

CAD	FY2018	FY2019	FY2020	FY2021	FY2022
Revenue	CAD 55.2M	CAD 245.5M	CAD 268.7M	CAD 245.3M	CAD 221.3M
Gross Profit	CAD 43.5M	CAD 142.4M	CAD -19.9M	CAD -21.6M	CAD 21.2M
Operating Income	CAD -95.8M	CAD -318.3M	CAD -465.8M	CAD -282.8M	CAD -231.4M
Net Income	CAD 69.2M	CAD -300.6M	CAD -3.3B	CAD -695.1M	CAD -1.7B
Diluted EPS	CAD 0.15	CAD -0.29	—	CAD -4.10	CAD -7.99
Operating Cash Flow	CAD -81.7M	CAD -192.2M	CAD -342.1M	CAD -210.6M	CAD -110.3M
Free Cash Flow	CAD -218.6M	CAD -606.5M	—	CAD -263.7M	CAD -142.5M

Deep dive

Computed from the SEC EDGAR multi-year statements

Operating leverage — margins

GrossOperatingNet

FY22 cash-flow waterfall

Cash-flow detail unavailable in this filing.

—

Follow the news. Track the move.

ACB story timeline

Company updates and connected market context, with the dated price move attached.

Stories

Direct

Sector context/Regulation

Sep 23

Aurora Cannabis Files Application with Alberta Securities Commission to Protect Company Shareholders Having Identified Several Deficiencies in Curaleaf's Hostile Bid Disclosure

Aurora Cannabis has asked Alberta’s securities regulator to review alleged deficiencies in Curaleaf’s disclosure for its hostile bid. The filing creates a regulatory hurdle for Curaleaf’s offer and puts the adequacy of the bid materials before the commission.

Price history unavailable

PR Newswire · 6h ago

View both sides →

Follow the news. Track the move.